Stock Events

Stock Events

10x Genomics 

€51.84
201
-€2.28-4.21%Friday 16:30

Statistics

Day High
50.97
Day Low
49.37
52W High
77.2
52W Low
49.37
Volume
155
Avg. Volume
-
Mkt Cap
6.75B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

Nov 5Expected
Q2 2026
Next
-0.24
-0.2
-0.16
-0.12
Expected EPS
-0.23764868975999998
Actual EPS
N/A

Financials

-7.11%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
558.3MRevenue
-39.71MNet Income

Analyst Ratings

$60.32Average Price Target
The highest estimate is ⁦83.47⁩.
From 12 ratings within the last 6 months. This is not an investment recommendation.
Buy
42%
Hold
58%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 1KJ.XETRA. It's not an investment recommendation.
NVIDIA
52
NVDA
Apple
50
AAPL
Microsoft
46
MSFT
Amazon
46
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Illumina
ILMN
Mkt Cap35.63B
Illumina provides sequencing and array-based solutions for genetic analysis, directly competing in the genomics space with technologies that overlap with 10x Genomics' offerings.
Pacific Biosciences of California
PACB
Mkt Cap809.71M
Pacific Biosciences offers long-read sequencing technologies that compete with 10x Genomics' products for genomic and transcriptomic analysis.
Bionano Genomics
BNGO
Mkt Cap16.07M
Bionano Genomics provides optical genome mapping solutions, which compete with 10x Genomics' chromosomal conformation capture technologies.
Intellia Therapeutics
NTLA
Mkt Cap1.75B
Intellia Therapeutics is involved in CRISPR gene editing, a field that requires detailed genomic analysis, where 10x Genomics' products are used.
CRISPR Therapeutics
CRSP
Mkt Cap4.97B
CRISPR Therapeutics is another key player in the gene editing space, relying on genomic insights where 10x Genomics' technologies can be applied.
Editas Medicine
EDIT
Mkt Cap410.06M
Editas Medicine operates in the genome editing sector, competing for the same genomic analysis market as 10x Genomics.
Teladoc Health
TDOC
Mkt Cap1.55B
Teladoc Health, while primarily a telehealth company, is expanding into primary care and chronic condition monitoring, indirectly competing with 10x Genomics in the data analysis and personalized medicine space.
Guardant Health
GH
Mkt Cap23.99B
Guardant Health specializes in liquid biopsies and cancer diagnostics, competing with 10x Genomics in the genomic analysis market for oncology.
Twist Bioscience
TWST
Mkt Cap10.13B
Twist Bioscience operates in the synthetic biology space, producing synthetic DNA that is used in many of the same applications as 10x Genomics' products.

About

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).
Show More
CEO
Serge Saxonov
Employees
1178
Country
United States
ISIN
US88025U1097
WKN
000A2PPQJ

Listings

LSE
GB
0A88.LSE
STU
DE
1KJ.STU
XNAS
US
TXG
MU
DE
1KJ.MU

0 Comments

Share your thoughts

FAQs

What is 10x Genomics stock price today?▼
The current price of 1KJ.XETRA is €51.84 EUR — it has decreased by -4.21% in the past 24 hours. Watch 10x Genomics stock price performance more closely on the chart.
What is 10x Genomics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XETRA Stock Exchange exchange 10x Genomics stocks are traded under the ticker 1KJ.XETRA.
What is 10x Genomics market cap?▼
Today 10x Genomics has the market capitalization of 6.75B
When is the next 10x Genomics earnings date?▼
10x Genomics is going to release the next earnings report on February 17, 2027.
What is 10x Genomics revenue for the last year?▼
10x Genomics revenue for the last year amounts to 558.3M EUR.
What is 10x Genomics net income for the last year?▼
1KJ.XETRA net income for the last year is -39.71M EUR.
How many employees does 10x Genomics have?▼
As of November 8, 2026, the company has 1,178 employees.
In which sector is 10x Genomics located?▼
10x Genomics operates in the Health & Wellness sector.
When did 10x Genomics complete a stock split?▼
10x Genomics has not had any recent stock splits.
Where is 10x Genomics headquartered?▼
10x Genomics is headquartered in PLEASANTON, United States.